After taking a shot at becoming a neuroscience biotech, buzzy Bay Area AI outfit Verge Genomics is dropping its only clinical asset and returning to its drug discovery roots. The decision comes after ...

Tony Dokoupil is the anchor of the new "CBS Evening News with Tony Dokoupil." He previously served as co-host of "CBS Mornings" and anchored "The Uplift," a weekly series spotlighting positive and ...

The era of predictive genomics is rapidly reshaping how we think about disease, risk and lifelong health. Recent advances in whole-genome sequencing have equipped clinicians with insights into our ...

In 2018, Chinese scientist He Jiankui shocked the world when he revealed that he had created the first gene-edited babies. Using Crispr, he tweaked the genes of three human embryos in an attempt to ...

Genomic approaches have transformed how we study microorganisms, which shape nearly every aspect of life on Earth. Featuring a range of article types, including Reviews, Comments and Journal Club ...

Shares of Intellia Therapeutics (NASDAQ:NTLA) rose 6% after Citizens JMP Securities upgraded the stock from Market Perform to Market Outperform with a new $33 price target, citing a strengthened ...

Enhanced Genomics ('Enhanced'), the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for common diseases, today announced it has ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min 67-year-old company plans move ...

10x Genomics is bolstering its commitment to scaling single cell experiments through the acquisition of Scale Biosciences. 10x has agreed to pay $30 million in cash and stock upfront, plus an ...

Irvine-based cancer diagnostics firm Helio Genomics has announced its appointment of Dr. Bharat Tewarie as its new chief executive. Current CEO Justin Chen Li, a founding member of the company, will ...